BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

762 related articles for article (PubMed ID: 25946437)

  • 21. Clinical impact of aortic regurgitation after transcatheter aortic valve replacement: insights into the degree and acuteness of presentation.
    Jerez-Valero M; Urena M; Webb JG; Tamburino C; Munoz-Garcia AJ; Cheema A; Dager AE; Serra V; Amat-Santos IJ; Barbanti M; Immè S; Alonso Briales JH; Al Lawati H; Benitez LM; Cucalon AM; Garcia del Blanco B; Revilla A; Dumont E; Barbosa Ribeiro H; Nombela-Franco L; Bergeron S; Pibarot P; Rodés-Cabau J
    JACC Cardiovasc Interv; 2014 Sep; 7(9):1022-32. PubMed ID: 25234675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcatheter aortic valve implantation with the Edwards SAPIEN versus the Medtronic CoreValve Revalving system devices: a multicenter collaborative study: the PRAGMATIC Plus Initiative (Pooled-RotterdAm-Milano-Toulouse In Collaboration).
    Chieffo A; Buchanan GL; Van Mieghem NM; Tchetche D; Dumonteil N; Latib A; van der Boon RM; Vahdat O; Marcheix B; Farah B; Serruys PW; Fajadet J; Carrié D; de Jaegere PP; Colombo A
    J Am Coll Cardiol; 2013 Feb; 61(8):830-6. PubMed ID: 23333140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry.
    Nazif TM; Dizon JM; Hahn RT; Xu K; Babaliaros V; Douglas PS; El-Chami MF; Herrmann HC; Mack M; Makkar RR; Miller DC; Pichard A; Tuzcu EM; Szeto WY; Webb JG; Moses JW; Smith CR; Williams MR; Leon MB; Kodali SK;
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):60-9. PubMed ID: 25616819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of balloon expandable transcatheter valves for valve-in-valve implantation in patients with degenerative stentless aortic bioprostheses: Technical considerations and results.
    Bapat V; Davies W; Attia R; Hancock J; Bolter K; Young C; Redwood S; Thomas M
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):917-22; discussion 922-4. PubMed ID: 25037622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex differences in postprocedural aortic regurgitation and mid-term mortality after transcatheter aortic valve implantation.
    Ferrante G; Pagnotta P; Petronio AS; Bedogni F; Brambilla N; Fiorina C; Giannini C; Mennuni M; De Marco F; Klugmann S; Ettori F; Presbitero P
    Catheter Cardiovasc Interv; 2014 Aug; 84(2):264-71. PubMed ID: 24408011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes with post-dilation following transcatheter aortic valve replacement: the PARTNER I trial (placement of aortic transcatheter valve).
    Hahn RT; Pibarot P; Webb J; Rodes-Cabau J; Herrmann HC; Williams M; Makkar R; Szeto WY; Main ML; Thourani VH; Tuzcu EM; Kapadia S; Akin J; McAndrew T; Xu K; Leon MB; Kodali SK
    JACC Cardiovasc Interv; 2014 Jul; 7(7):781-9. PubMed ID: 25060022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DynaCT-guided anatomical rotation of the SAPIEN XT valve during transapical aortic valve implantation: proof of concept.
    Blumenstein JM; Van Linden A; Moellmann H; Seeburger J; Rastan A; Kim WK; Mohr FW; Kempfert J; Walther T
    Thorac Cardiovasc Surg; 2013 Aug; 61(5):409-13. PubMed ID: 23247690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility and safety of transfemoral implantation of Edwards SAPIEN XT prosthesis without balloon valvuloplasty in severe stenosis of native aortic valve.
    García E; Martín P; Hernández R; Rodríguez V; Fernández A; Gama V; Almería C; Macaya C
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):791-5. PubMed ID: 24285561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry.
    Bosmans JM; Kefer J; De Bruyne B; Herijgers P; Dubois C; Legrand V; Verheye S; Rodrigus I;
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):762-7. PubMed ID: 21349890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve.
    Mussardo M; Latib A; Chieffo A; Godino C; Ielasi A; Cioni M; Takagi K; Davidavicius G; Montorfano M; Maisano F; Carlino M; Franco A; Covello RD; Spagnolo P; Grimaldi A; Alfieri O; Colombo A
    JACC Cardiovasc Interv; 2011 Jul; 4(7):743-50. PubMed ID: 21777881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVR.
    Martinez CA; Singh V; O'Neill BP; Alfonso CE; Bilsker MS; Martinez Clark P; Williams D; Cohen MG; Heldman AW; O'Neill WW
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):300-11. PubMed ID: 23580318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transapical transcatheter aortic valve implantation: follow-up to 3 years.
    Ye J; Cheung A; Lichtenstein SV; Nietlispach F; Albugami S; Masson JB; Thompson CR; Munt B; Moss R; Carere RG; Jamieson WR; Webb JG
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1107-13, 1113.e1. PubMed ID: 20412948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trans-subclavian versus transapical access for transcatheter aortic valve implantation: A multicenter study.
    Ciuca C; Tarantini G; Latib A; Gasparetto V; Savini C; Di Eusanio M; Napodano M; Maisano F; Gerosa G; Sticchi A; Marzocchi A; Alfieri O; Colombo A; Saia F
    Catheter Cardiovasc Interv; 2016 Feb; 87(2):332-8. PubMed ID: 26010724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of pre- and post-procedural anemia on the incidence of acute kidney injury and 1-year mortality in patients undergoing transcatheter aortic valve implantation (from the French Aortic National CoreValve and Edwards 2 [FRANCE 2] Registry).
    Arai T; Morice MC; O'Connor SA; Yamamoto M; Eltchaninoff H; Leguerrier A; Leprince P; Laskar M; Iung B; Fajadet J; Prat A; Lièvre M; Donzeau-Gouge P; Chevreul K; Teiger E; Lefèvre T; Gilard M;
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1231-9. PubMed ID: 25641110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. When does transapical aortic valve replacement become a futile procedure? An analysis from a national registry.
    D'Onofrio A; Salizzoni S; Agrifoglio M; Lucchetti V; Musumeci F; Esposito G; Magagna P; Aiello M; Savini C; Cassese M; Glauber M; Punta G; Alfieri O; Gabbieri D; Mangino D; Agostinelli A; Livi U; Di Gregorio O; Minati A; Faggian G; Filippini C; Rinaldi M; Gerosa G
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):973-9; discussion 979-80. PubMed ID: 25018158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different impact of sex on baseline characteristics and major periprocedural outcomes of transcatheter and surgical aortic valve interventions: Results of the multicenter Italian OBSERVANT Registry.
    Onorati F; D'Errigo P; Barbanti M; Rosato S; Covello RD; Maraschini A; Ranucci M; Santoro G; Tamburino C; Grossi C; Santini F; Menicanti L; Seccareccia F;
    J Thorac Cardiovasc Surg; 2014 May; 147(5):1529-39. PubMed ID: 23856202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treating the patients in the 'grey-zone' with aortic valve disease: a comparison among conventional surgery, sutureless valves and transcatheter aortic valve replacement.
    Muneretto C; Bisleri G; Moggi A; Di Bacco L; Tespili M; Repossini A; Rambaldini M
    Interact Cardiovasc Thorac Surg; 2015 Jan; 20(1):90-5. PubMed ID: 25320140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of balloon post-dilation on clinical outcomes after transcatheter aortic valve replacement with the self-expanding CoreValve prosthesis.
    Barbanti M; Petronio AS; Capodanno D; Ettori F; Colombo A; Bedogni F; De Marco F; De Carlo M; Fiorina C; Latib A; Testa L; Bruschi G; Poli A; Giannini C; Curello S; Maffeo D; Sgroi C; Martina P; Gulino S; Patanè M; Ohno Y; Attizzani GF; Immè S; Cannata S; Gentili A; Rossi A; Tamburino C
    JACC Cardiovasc Interv; 2014 Sep; 7(9):1014-21. PubMed ID: 25234674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcatheter aortic valve replacement with the SAPIEN 3: a new balloon-expandable transcatheter heart valve.
    Binder RK; Rodés-Cabau J; Wood DA; Mok M; Leipsic J; De Larochellière R; Toggweiler S; Dumont E; Freeman M; Willson AB; Webb JG
    JACC Cardiovasc Interv; 2013 Mar; 6(3):293-300. PubMed ID: 23517842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical impact of paravalvular leaks on biomarkers and survival after transcatheter aortic valve implantation.
    Schewel D; Frerker C; Schewel J; Wohlmuth P; Meincke F; Thielsen T; Kreidel F; Kuck KH; Schäfer U
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):502-14. PubMed ID: 24259366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.